Literature DB >> 8786520

[Does acamprosate diminish the appetite for alcohol in weaned alcoholics?].

J P Roussaux1, D Hers, M Ferauge.   

Abstract

A population of 127 alcoholics of both sexes, hospitalized and weaned (DSM III diagnose: Alcohol Abuse and Alcohol Dependence) received Acamprosate (n = 63) or placebo (n = 64) in a double blind randomized therapeutic trail. The patients were followed during three months and anamnestic as well as biological data were recorded. It appeared no significant differences between the two groups of patients. This negative result could perhaps be explained by the heaviness of the pathology of this hospitalized alcoholic population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786520

Source DB:  PubMed          Journal:  J Pharm Belg        ISSN: 0047-2166


  7 in total

Review 1.  The development of acamprosate as a treatment against alcohol relapse.

Authors:  Peter R Kufahl; Lucas R Watterson; M Foster Olive
Journal:  Expert Opin Drug Discov       Date:  2014-09-26       Impact factor: 6.098

Review 2.  Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

Authors:  Barbara J Mason; Charles J Heyser
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 3.  [Pharmacological relapse prevention in alcohol and tobacco dependence].

Authors:  A Diehl; K Mann
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

4.  Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Authors:  Barbara J Mason; Philippe Lehert
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

5.  Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy.

Authors:  Sandeep Grover; Debasish Basu; Gaurav Bhateja
Journal:  Indian J Psychiatry       Date:  2007-01       Impact factor: 1.759

Review 6.  Pharmacotherapy of alcohol dependence: a review of the clinical data.

Authors:  Karl Mann
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Authors:  Stephanie L Yahn; Lucas R Watterson; M Foster Olive
Journal:  Subst Abuse       Date:  2013-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.